Omeros | OMER - Market Capitalization


Omeros reported $1.09B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 2.15B 2.19B Mar/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
BioMarin Pharmaceutical USD 11.71B 651M Aug/2026
Cytokinetics USD 9.6B 1.95B Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
Heron Therapeutics USD 238M 7M Dec/2025
Immunic USD 64M 23M Dec/2025
Insmed USD 19.68B 3.43B Aug/2026
MacroGenics USD 184M 82M Mar/2026
Pacira USD 1.28B 286M Aug/2026
Pfizer USD 153.17B 14.73B Aug/2026
Sarepta Therapeutics USD 1.5B 402M Aug/2026
United Therapeutics USD 24.42B 1.42B Aug/2026
Vertex Pharmaceuticals USD 137.33B 11.26B Aug/2026